Recent advances in calcium peroxide nanomedicines for breast cancer treatment
- PMID: 40768102
- PMCID: PMC12328860
- DOI: 10.1007/s12672-025-03329-x
Recent advances in calcium peroxide nanomedicines for breast cancer treatment
Abstract
As a typical solid tumor, breast cancer is characterized by a tumor microenvironment featuring hypoxia, acidosis, and highly reductive conditions. These factors contribute to treatment resistance (e.g., chemoresistance) through various mechanisms, thereby diminishing therapeutic efficacy. Calcium peroxide (CaO2) can generate multiple bioactive molecules (metal ions, H2O2, O2, and OH-) in acidic or neutral environment, making it a promising biomaterial for cancer therapy. Recently, breast cancer has been extensively targeted using CaO2 nanoparticles in both cellular and murine models. In this review, we first provide a summary of strategies employing CaO2 nanomedicine-based breast cancer therapies, then discuss the obstacles and development directions of CaO2 application in breast cancer therapy.
Keywords: Breast cancer; CaO2; Hypoxia; ROS.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval: Not applicable. Consent to participate: Not applicable. Consent to publish: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23. Clin Orthop Relat Res. 2024. PMID: 39051924
-
The Lived Experience of Autistic Adults in Employment: A Systematic Search and Synthesis.Autism Adulthood. 2024 Dec 2;6(4):495-509. doi: 10.1089/aut.2022.0114. eCollection 2024 Dec. Autism Adulthood. 2024. PMID: 40018061 Review.
-
Network pharmacology and in silico approach to study the mechanism of quercetin against breast cancer.In Silico Pharmacol. 2025 Feb 6;13(1):22. doi: 10.1007/s40203-025-00306-8. eCollection 2025. In Silico Pharmacol. 2025. PMID: 39925462
-
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100. Epidemiol Prev. 2013. PMID: 23851286 Italian.
References
-
- Kim J, Harper A, Mccormack V, Sung H, Houssami N, Morgan E, Mutebi M, Garvey G, Soerjomataram I. Fidler-benaoudia, global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;16:1174. 10.1038/s41591-025-03502-3. - PubMed
-
- Debnath A, Mazumder R. Clinical progress of targeted for breast cancer:a comprehensive review, curr. Cancer Drug Targets. 2025;25:e020424228537. 10.2174/0115680096289260240311062343. - PubMed
-
- Yuan CS, Deng ZW, Qin D, Mu YZ, Chen XG, Liu Y. Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand? Acta Biomater. 2021;125:1–28. 10.1016/j.actbio.2021.02.030. - PubMed
-
- He C, Zhang S, Liu X, Wang J, Huang Y, Zhang A, Zhang X. CaO2 nanomedicines: a review of their emerging roles in cancer therapy. Nanotechnology. 2023;34:482002. 10.1088/1361-6528/acf381. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials